Literature DB >> 2110121

Late onset globoid leukodystrophy: unusual clinical and CSF findings.

S Rolando1, M Cremonte, A Leonardi.   

Abstract

During a febrile upper respiratory tract illness this 4 year old boy developed left hemiparesis, which progressed to loss of walking and even of sitting finally to tetraplegia. The cerebrospinal fluid protein pattern showed blood-brain barrier damage with additional intrathecal IgG synthesis. The symptoms responded to steroid therapy but resumed and worsened on withdrawal. Only late, when visual evoked potentials and nerve conduction velocity proved to be impaired, was Krabbe disease diagnosed on the assay of cultured fibroblasts for galactocerebroside-beta-galactosidase. We discuss the significance of possible endogenous production of IgG in the CNS.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2110121     DOI: 10.1007/bf02334906

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  8 in total

1.  Globoid leukidystrophy. I. Clinical and enzymatic studies.

Authors:  M J Malone; M C Szöke; G L Looney
Journal:  Arch Neurol       Date:  1975-09

2.  Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values.

Authors:  G Tibbling; H Link; S Ohman
Journal:  Scand J Clin Lab Invest       Date:  1977-09       Impact factor: 1.713

3.  Late onset globoid cell leucodystrophy.

Authors:  L Crome; F Hanefeld; D Patrick; J Wilson
Journal:  Brain       Date:  1973-12       Impact factor: 13.501

4.  The discrimination between different blood-CSF barrier dysfunctions and inflammatory reactions of the CNS by a recent evaluation graph for the protein profile of cerebrospinal fluid.

Authors:  H Reiber
Journal:  J Neurol       Date:  1980       Impact factor: 4.849

5.  Krabbe's disease: clinical presentation of neurological variants.

Authors:  B Hagberg
Journal:  Neuropediatrics       Date:  1984-09       Impact factor: 1.947

6.  Late-onset globoid cell leucodystrophy (Krabbe's disease). Clinical and genetic delineation of two forms and their relation to the early-infantile form.

Authors:  M C Loonen; O P Van Diggelen; H C Janse; W J Kleijer; W F Arts
Journal:  Neuropediatrics       Date:  1985-08       Impact factor: 1.947

7.  The basis of intra-blood-brain-barrier IgG synthesis.

Authors:  W W Tourtellotte; S M Staugaitis; M J Walsh; P Shapshak; R W Baumhefner; A R Potvin; K Syndulko
Journal:  Ann Neurol       Date:  1985-01       Impact factor: 10.422

8.  Multiple sclerosis: measurement and validation of central nervous system IgG synthesis rate.

Authors:  W W Tourtellotte; A R Potvin; J O Fleming; K N Murthy; J Levy; K Syndulko; J H Potvin
Journal:  Neurology       Date:  1980-03       Impact factor: 9.910

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.